Prix De L'Action
47.40
Variation Quotidienne
-0.08 -0.17%
Mensuellement
2.40%
Annuel
93.55%
Q1 Prévisions
45.93




Capitaux D'Emprunt Changement Date
Akebia Therapeutics USD 47.64M 579K 2025-09
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.67M 95K 2025-06
Moderna USD 610M 584M 2025-12
Organigram Holdings CAD 76.4M 23.6M 2025-09
Organon & Co USD 8.78B 117M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 37.75M 180K 2025-09
Qiagen NV USD 1.65B 15.23M 2025-12
Revvity USD 2.63B 543K 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 100K 86K 2025-09
Tilray USD 279.22M 18.87M 2025-03
Viatris USD 12.49B 304M 2025-09
Xeris Pharmaceuticals USD 219.47M 839K 2025-09
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09


Dianthus Therapeutics Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.